The second factor we look at for the Magic Wand Index is the perceived Benefit of moving forward with the solution in question. For patients, this could be a number of things – including getting access to potential treatments before they are released to the general public, doing something of value to the patient community, getting regular health checks outside of your normal healthcare plan, or even simply getting paid to take part – which is sometimes one of the main drivers of participation, especially for phase one trials.

For sponsors, the solution should be able to provide them with patients who will qualify for the trial and stick with it through to completion. Incorporating time and cost saving resources into the service – for instance, by providing a site follow-up mechanism and a user-friendly patient platform with transparent reporting capabilities – could also be seen as beneficial.